Tixagevimab/Cilgavimab as SARS-CoV-2 Pre-Exposure Prophylaxis in Lung Transplant Recipients during the Omicron Wave: A Real-World Monocentric Experience

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Microorganisms

Topics

Physics

Optics

Medicine

Epidemiology

Internal Medicine

Show all topics

DOI

10.3390/microorganisms12071436

License

CC-BY

Other Formats

PDF